SCHEMBL20122478

SCHEMBL20122478

CC(C)(S)C(=O)N[C@@H](CSC(=O)OCOC(=O)c1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.43
▸ SLC6A3 Q01959 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ ACE P12821 2/20 0.42
▸ MME P08473 2/20 0.42
▸ ACE2 Q9BYF1 1/20 0.42
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ FNTA P49354 1/20 0.38
▸ FNTB P49356 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ADRB2 P07550 2/20 0.37
▸ ADRB1 P08588 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122544 0.90 MME (0.43) ACEMMEACE2PPARGPPARA
SCHEMBL20122369 0.90 ACE (0.41) KMT2ASLC6A3TDP1ACEMME
SCHEMBL20122368 0.90 ACE (0.42) KMT2ASLC6A3TDP1ACEMME
SCHEMBL20122394 0.89 KMT2A (0.42) KMT2ASLC6A3TDP1SLC6A2ACE
SCHEMBL20122362 0.89 ACE (0.42) ACEMMEACE2PPARAFNTA
SCHEMBL20122588 0.89 ACE (0.48) SLC6A3TDP1ACEMMEACE2
SCHEMBL20122366 0.88 ACE (0.41) SLC6A3TDP1ACEMMEACE2
SCHEMBL20122476 0.87 ACE (0.40) KMT2ASLC6A3TDP1ACEMME
SCHEMBL20122365 0.87 ACE (0.40) SLC6A3TDP1ACEMMEACE2
SCHEMBL20122496 0.85 ACE (0.34) ACEMMEACE2ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback